Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease

NCT01019421 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

278

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease

Interventions

DRUG: Lu AE58054
DRUG: Placebo

Sponsor

H. Lundbeck A/S